Effectiveness and Safety of Medical Abortion with Mifepristone and Sublingual Misoprostol up to 63 Days of Gestation

Effectiveness and Safety of Medical Abortion with Mifepristone and Sublingual Misoprostol up to 63 Days of Gestation

Background: The use of medical abortion increases among unplanned pregnant women. The primary objective of this study is to assess the outcomes of using a combination of Mifepristone followed by sublingual Misoprostol for the termination of pregnancy up to 63 gestational days. The...

Full description

Bibliographic Details
Main Authors: Prakasit Saengbanyang, Thanyarat Wongwananuruk, Nalinee Panichyawat, Natchara Sukapatrittikul Powell, Nichamon Parkpinyo
Format: Article
Language:English
Published: IMR Press 2024-09-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
medical abortion
medical induced abortion
medical termination of pregnancy
mifepristone
misoprostol
incomplete abortion
Online Access:https://www.imrpress.com/journal/CEOG/51/10/10.31083/j.ceog5110218

Internet

https://www.imrpress.com/journal/CEOG/51/10/10.31083/j.ceog5110218

Similar Items